K. Watanabe et al., Subacute and chronic effects of DDD pacing on left ventricular diastolic function in patients with non-obstructive hypertrophic cardiomyopathy, JPN CIRC J, 65(4), 2001, pp. 283-288
Citations number
24
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
The present study examined the ability of dual-chamber (DDD) pacing to impr
ove symptoms and exercise tolerance in patients with non-obstructive hypert
rophic cardiomyopathy (HNCM). Seven patients with HNCM who had failed to be
nefit fi om pharmacotherapy participated in the study. The New York Heart A
ssociation (NHYA) functional class status and exercise tolerance, which was
determined by the treadmill exercise test, were recorded and an echocardio
graphic observation was performed before, and 1 week, 3 months and 1 year a
fter the implantation of a permanent DDD pacemaker. The atrioventricular de
lay (AVd) was determined by measuring the point of peak rapid filling veloc
ity and maximum cardiac output (CO). Two patients were not implanted with a
permanent pacemaker because their CO and blood pressure decreased or becau
se palpitation occurred during temporary pacing. The ratio between early an
d late peaks of how velocity (1.56, 1.21, 0.95, and 0.86 before implantatio
n and 1 week, 3 months and 1 year after implantation, respectively); decele
ration time (ms: 263.2, 217.6, 204.6, 187.0); peal; filling late (ml/s: 146
.3, 704.0, 233.2, 243.6); NYHA functional class status (2.0, 1.8, 1.6, 1.3)
; and exercise tolerance (s: 203, 264, 403, 480) were significantly improve
d after implantation. However, left ventricular dimension, percent fraction
al shortening, ejection fraction, acceleration time and the isovolumic rela
xation time were not changed significantly. In conclusion, DDD pacing impro
ved symptoms and the NYHA functional class status, which is associated with
improvement of left ventricular diastolic function, it is proposed that DD
D pacing would be useful in patients not only with obstructive but also non
-obstructive hypertrophic cardiomyopathy refractory to medical treatment, d
epending on the careful selection of subjects.